Literature DB >> 19171884

Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS.

Jiou Wang1, George W Farr, Caroline J Zeiss, Diego J Rodriguez-Gil, Jean H Wilson, Krystyna Furtak, D Thomas Rutkowski, Randal J Kaufman, Cristian I Ruse, John R Yates, Steve Perrin, Mel B Feany, Arthur L Horwich.   

Abstract

Recent studies suggest that superoxide dismutase 1 (SOD1)-linked amyotrophic lateral sclerosis results from destabilization and misfolding of mutant forms of this abundant cytosolic enzyme. Here, we have tracked the expression and fate of a misfolding-prone human SOD1, G85R, fused to YFP, in a line of transgenic G85R SOD1-YFP mice. These mice, but not wild-type human SOD1-YFP transgenics, developed lethal paralyzing motor symptoms at 9 months. In situ RNA hybridization of spinal cords revealed predominant expression in motor neurons in spinal cord gray matter in all transgenic animals. Concordantly, G85R SOD-YFP was diffusely fluorescent in motor neurons of animals at 1 and 6 months of age, but at the time of symptoms, punctate aggregates were observed in cell bodies and processes. Biochemical analyses of spinal cord soluble extracts indicated that G85R SOD-YFP behaved as a misfolded monomer at all ages. It became progressively insoluble at 6 and 9 months of age, associated with presence of soluble oligomers observable by gel filtration. Immunoaffinity capture and mass spectrometry revealed association of G85R SOD-YFP, but not WT SOD-YFP, with the cytosolic chaperone Hsc70 at all ages. In addition, 3 Hsp110's, nucleotide exchange factors for Hsp70s, were captured at 6 and 9 months. Despite such chaperone interactions, G85R SOD-YFP formed insoluble inclusions at late times, containing predominantly intermediate filament proteins. We conclude that motor neurons, initially "compensated" to maintain the misfolded protein in a soluble state, become progressively unable to do so.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171884      PMCID: PMC2631083          DOI: 10.1073/pnas.0813045106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Heterodimeric structure of superoxide dismutase in complex with its metallochaperone.

Authors:  A L Lamb; A S Torres; T V O'Halloran; A C Rosenzweig
Journal:  Nat Struct Biol       Date:  2001-09

2.  DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics.

Authors:  David L Tabb; W Hayes McDonald; John R Yates
Journal:  J Proteome Res       Date:  2002 Jan-Feb       Impact factor: 4.466

3.  Structure of the Hsp110:Hsc70 nucleotide exchange machine.

Authors:  Jonathan P Schuermann; Jianwen Jiang; Jorge Cuellar; Oscar Llorca; Liping Wang; Luis E Gimenez; Suping Jin; Alexander B Taylor; Borries Demeler; Kevin A Morano; P John Hart; Jose M Valpuesta; Eileen M Lafer; Rui Sousa
Journal:  Mol Cell       Date:  2008-06-12       Impact factor: 17.970

4.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology.

Authors:  M P Washburn; D Wolters; J R Yates
Journal:  Nat Biotechnol       Date:  2001-03       Impact factor: 54.908

5.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury.

Authors:  A G Reaume; J L Elliott; E K Hoffman; N W Kowall; R J Ferrante; D F Siwek; H M Wilcox; D G Flood; M F Beal; R H Brown; R W Scott; W D Snider
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

6.  Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.

Authors:  Ganesh M Shankar; Shaomin Li; Tapan H Mehta; Amaya Garcia-Munoz; Nina E Shepardson; Imelda Smith; Francesca M Brett; Michael A Farrell; Michael J Rowan; Cynthia A Lemere; Ciaran M Regan; Dominic M Walsh; Bernardo L Sabatini; Dennis J Selkoe
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

7.  Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function.

Authors:  D R Borchelt; M Guarnieri; P C Wong; M K Lee; H S Slunt; Z S Xu; S S Sisodia; D L Price; D W Cleveland
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

8.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

Review 9.  Unraveling the mechanisms involved in motor neuron degeneration in ALS.

Authors:  Lucie I Bruijn; Timothy M Miller; Don W Cleveland
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

10.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Authors:  Monica Bucciantini; Elisa Giannoni; Fabrizio Chiti; Fabiana Baroni; Lucia Formigli; Jesús Zurdo; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson; Massimo Stefani
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

View more
  78 in total

Review 1.  Designing phenotyping studies for genetically engineered mice.

Authors:  C J Zeiss; J M Ward; H G Allore
Journal:  Vet Pathol       Date:  2011-09-19       Impact factor: 2.221

2.  Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis.

Authors:  Radhia Benmohamed; Anthony C Arvanites; Jinho Kim; Robert J Ferrante; Richard B Silverman; Richard I Morimoto; Donald R Kirsch
Journal:  Amyotroph Lateral Scler       Date:  2010-11-12

3.  Thermodynamics of protein destabilization in live cells.

Authors:  Jens Danielsson; Xin Mu; Lisa Lang; Huabing Wang; Andres Binolfi; François-Xavier Theillet; Beata Bekei; Derek T Logan; Philipp Selenko; Håkan Wennerström; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

4.  Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.

Authors:  Per Zetterström; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Stefan L Marklund
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

Review 5.  The structural biochemistry of the superoxide dismutases.

Authors:  J J P Perry; D S Shin; E D Getzoff; J A Tainer
Journal:  Biochim Biophys Acta       Date:  2009-11-13

6.  Dysregulation of the proteasome increases the toxicity of ALS-linked mutant SOD1.

Authors:  Akira Kitamura; Noriko Inada; Hiroshi Kubota; Gen Matsumoto; Masataka Kinjo; Richard I Morimoto; Kazuhiro Nagata
Journal:  Genes Cells       Date:  2014-01-23       Impact factor: 1.891

7.  Absence of lipofuscin in motor neurons of SOD1-linked ALS mice.

Authors:  Urmi Bandyopadhyay; Maria Nagy; Wayne A Fenton; Arthur L Horwich
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

Review 8.  Cellular strategies of protein quality control.

Authors:  Bryan Chen; Marco Retzlaff; Thomas Roos; Judith Frydman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

9.  Functional diversity between HSP70 paralogs caused by variable interactions with specific co-chaperones.

Authors:  Despina Serlidaki; Maria A W H van Waarde; Lukas Rohland; Anne S Wentink; Suzanne L Dekker; Maarten J Kamphuis; Jeffrey M Boertien; Jeanette F Brunsting; Nadinath B Nillegoda; Bernd Bukau; Matthias P Mayer; Harm H Kampinga; Steven Bergink
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

10.  Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.

Authors:  Jacob I Ayers; Susan E Fromholt; Veronica M O'Neal; Jeffrey H Diamond; David R Borchelt
Journal:  Acta Neuropathol       Date:  2015-12-09       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.